124 related articles for article (PubMed ID: 21605661)
1. Soy isoflavones sensitize cancer cells to radiotherapy.
Hillman GG; Singh-Gupta V
Free Radic Biol Med; 2011 Jul; 51(2):289-98. PubMed ID: 21605661
[TBL] [Abstract][Full Text] [Related]
2. Radiation-induced HIF-1alpha cell survival pathway is inhibited by soy isoflavones in prostate cancer cells.
Singh-Gupta V; Zhang H; Banerjee S; Kong D; Raffoul JJ; Sarkar FH; Hillman GG
Int J Cancer; 2009 Apr; 124(7):1675-84. PubMed ID: 19101986
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 expression by soy isoflavones enhances prostate cancer radiotherapy in vitro and in vivo.
Raffoul JJ; Banerjee S; Singh-Gupta V; Knoll ZE; Fite A; Zhang H; Abrams J; Sarkar FH; Hillman GG
Cancer Res; 2007 Mar; 67(5):2141-9. PubMed ID: 17332344
[TBL] [Abstract][Full Text] [Related]
4. Soy isoflavones augment radiation effect by inhibiting APE1/Ref-1 DNA repair activity in non-small cell lung cancer.
Singh-Gupta V; Joiner MC; Runyan L; Yunker CK; Sarkar FH; Miller S; Gadgeel SM; Konski AA; Hillman GG
J Thorac Oncol; 2011 Apr; 6(4):688-98. PubMed ID: 21325978
[TBL] [Abstract][Full Text] [Related]
5. Soy isoflavones suppress invasiveness of breast cancer cells by the inhibition of NF-kappaB/AP-1-dependent and -independent pathways.
Valachovicova T; Slivova V; Bergman H; Shuherk J; Sliva D
Int J Oncol; 2004 Nov; 25(5):1389-95. PubMed ID: 15492830
[TBL] [Abstract][Full Text] [Related]
6. Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones.
Guo Y; Wang S; Hoot DR; Clinton SK
J Nutr Biochem; 2007 Jun; 18(6):408-17. PubMed ID: 17142033
[TBL] [Abstract][Full Text] [Related]
7. Soy Isoflavones Protect Normal Tissues While Enhancing Radiation Responses.
Hillman GG
Semin Radiat Oncol; 2019 Jan; 29(1):62-71. PubMed ID: 30573186
[TBL] [Abstract][Full Text] [Related]
8. Lycopene and soy isoflavones in the treatment of prostate cancer.
Vaishampayan U; Hussain M; Banerjee M; Seren S; Sarkar FH; Fontana J; Forman JD; Cher ML; Powell I; Pontes JE; Kucuk O
Nutr Cancer; 2007; 59(1):1-7. PubMed ID: 17927495
[TBL] [Abstract][Full Text] [Related]
9. Soy isoflavones augment the effect of TRAIL-mediated apoptotic death in prostate cancer cells.
Szliszka E; Krol W
Oncol Rep; 2011 Sep; 26(3):533-41. PubMed ID: 21637922
[TBL] [Abstract][Full Text] [Related]
10. The specific role of isoflavones in reducing prostate cancer risk.
Kumar NB; Cantor A; Allen K; Riccardi D; Besterman-Dahan K; Seigne J; Helal M; Salup R; Pow-Sang J
Prostate; 2004 May; 59(2):141-7. PubMed ID: 15042614
[TBL] [Abstract][Full Text] [Related]
11. Isoflavones made simple - genistein's agonist activity for the beta-type estrogen receptor mediates their health benefits.
McCarty MF
Med Hypotheses; 2006; 66(6):1093-114. PubMed ID: 16513288
[TBL] [Abstract][Full Text] [Related]
12. Decreased growth of human prostate LNCaP tumors in SCID mice fed a low-fat, soy protein diet with isoflavones.
Aronson WJ; Tymchuk CN; Elashoff RM; McBride WH; McLean C; Wang H; Heber D
Nutr Cancer; 1999; 35(2):130-6. PubMed ID: 10693166
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor-β mediates the inhibition of DLD-1 human colon adenocarcinoma cells by soy isoflavones.
Bielecki A; Roberts J; Mehta R; Raju J
Nutr Cancer; 2011; 63(1):139-50. PubMed ID: 21161820
[TBL] [Abstract][Full Text] [Related]
14. Effects of soy isoflavones on apoptosis induction and G2-M arrest in human hepatoma cells involvement of caspase-3 activation, Bcl-2 and Bcl-XL downregulation, and Cdc2 kinase activity.
Su SJ; Chow NH; Kung ML; Hung TC; Chang KL
Nutr Cancer; 2003; 45(1):113-23. PubMed ID: 12791511
[TBL] [Abstract][Full Text] [Related]
15. Soy isoflavones in the treatment of prostate cancer.
Hussain M; Banerjee M; Sarkar FH; Djuric Z; Pollak MN; Doerge D; Fontana J; Chinni S; Davis J; Forman J; Wood DP; Kucuk O
Nutr Cancer; 2003; 47(2):111-7. PubMed ID: 15087261
[TBL] [Abstract][Full Text] [Related]
16. Relationship of dietary protein and soy isoflavones to serum IGF-1 and IGF binding proteins in the Prostate Cancer Lifestyle Trial.
Dewell A; Weidner G; Sumner MD; Barnard RJ; Marlin RO; Daubenmier JJ; Chi C; Carroll PR; Ornish D
Nutr Cancer; 2007; 58(1):35-42. PubMed ID: 17571965
[TBL] [Abstract][Full Text] [Related]
17. Retinoid-induced epidermal hyperplasia in human skin organ culture: inhibition with soy extract and soy isoflavones.
Varani J; Kelley EA; Perone P; Lateef H
Exp Mol Pathol; 2004 Dec; 77(3):176-83. PubMed ID: 15507233
[TBL] [Abstract][Full Text] [Related]
18. Soy intake and cancer risk: a review of the in vitro and in vivo data.
Messina MJ; Persky V; Setchell KD; Barnes S
Nutr Cancer; 1994; 21(2):113-31. PubMed ID: 8058523
[TBL] [Abstract][Full Text] [Related]
19. Addressing the soy and breast cancer relationship: review, commentary, and workshop proceedings.
Messina M; McCaskill-Stevens W; Lampe JW
J Natl Cancer Inst; 2006 Sep; 98(18):1275-84. PubMed ID: 16985246
[TBL] [Abstract][Full Text] [Related]
20. Radiosensitization of prostate cancer by soy isoflavones.
Raffoul JJ; Sarkar FH; Hillman GG
Curr Cancer Drug Targets; 2007 Dec; 7(8):759-65. PubMed ID: 18220535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
